head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2019, vol. 25, issue2
Subject Area: Dental Medicine
DOI: 10.5272/jimab.2019252.2516
Published online: 22 April 2019

Case report

J of IMAB. 2019 Apr-Jun;25(2):2516-2520
Elena FirkovaORCID logo Corresponding Autoremail,
Department of Periodontology and Oral Diseases, Faculty of Dental Medicine, Medical University – Plovdiv, Bulgaria.

Pemphigus vulgaris (PV), a rare autoimmune mucocutaneous blistering disorder, has been reported with an incidence of 0.1-0.5 cases per 100,000 individuals worldwide per year. It is slightly more common in women and occurs primarily in adults during the 5th or 6th decade of life. The etiology of PV is uncertain but is supposed to be mediated by circulating immunoglobulin G autoantibodies against the desmosomal cadherins, desmoglein 1 and 3. Biopsy, light microscopic examination, and additional adjuvant tests, such as immunofluorescence studies can be used to establish the diagnosis. In most cases (70-90%), the first signs of disease appear on the oral mucosa, but most patients with oral lesions are initially misdiagnosed and treated improperly for months or years. If these patients are misdiagnosed or left untreated, PV may be fatal with a mortality rate ranging from 60% to 90%. Therefore, here we discuss the basics of diagnosing and treating patients with PV and oral lesions.

Keywords: pemphigus, oral lesions, oral diagnosis, dental treatment,

pdf - Download FULL TEXT /PDF 1349 KB/
Please cite this article as: Firkova E. Dental Perspective of Pemphigus Vulgaris – A clinical case with Diagnostic and Treatment Guidelines. J of IMAB. 2019 Apr-Jun;25(2):2516-2520. DOI: 10.5272/jimab.2019252.2516

Corresponding AutorCorrespondence to: Assoc. Prof. Elena Firkova, PhD, DDS., Department of Periodontology and Oral Diseases, Faculty of Dental Medicine, Medical University – Plovdiv, Bulgaria; E-mail: elenafirkova@yahoo.com

1. Black M, Mignogna MD, Scully C. Number II. Pemphigus vulgaris. Oral Dis. 2005 May;11(3):119-30. [PubMed] [Crossref]
2. Amagai M. Autoimmune and infectious skin diseases that target desmogleins. Proc Jpn Acad Ser B Phys Biol Sci. 2010; 86(5):524-37 [PubMed]. 
3. Mutasim DF, Pelc NJ, Anhalt GJ. Drug-induced pemphigus. Dermatol Clin. 1993 Jul;11(3):463-71 [PubMed] [
4. Brenner S, Wolf R. Possible nutritional factors in induced pemphigus. Dermatology 1994; 189(4):337-9 [PubMed] [Crossref]
5. Tron F, Gilbert D, MouquetH, Joly P, Drout L, Makni S, et al. Genetic factors in pemphigus. J Autoimmun. 2005 Jun;24(4):319-28. [PubMed] [Crossref]
6.  Bascones-Martinez A, Munoz-Corcuera M, Bascones-Ilundain C, Esparza-Gуmez G. Oral Manifestations of Pemphigus Vulgaris: Clinical Presentation, Differential Diagnosis and Management. J Clin Exp Dermatol Res. 2010; 1:112 [Crossref]
7. Mignogna MD, Fortuna G, Leuci S, Ruoppo E, Marasca F, Matarasso S. Nikolsky’s sign on the gingival mucosa: a clinical tool for oral health practitioners. J Periodontol. 2008 Dec;79(12):2241-6 [PubMed] [Crossref]
8. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med 2007 May-Jun;11(3):462-81 [PubMed] [Crossref]
9. Yeh SW, Sami N, Ahmed RA. Treatment of pemphigus vulgaris: Current and emerging options. Am J Clin Dermatol. 2005; 6(5):327-42 [PubMed] [Crossref]
10. Prajapati V, Mydlarski PR. Advances in pemphigus therapy. Skin Therapy Lett. 2008 Apr;13(3):4-7 [PubMed] .
11. Scully C, Mignogna M. Oral mucosal disease: Pemphigus. Br J Oral Maxillofac Surg. 2008 Jun;46(4):272-7.  [PubMed] [Crossref]
12. Ruocco E, Baroni A, Wolf R, Ruocco V. Life-threatening bullous dermatoses: Pemphigus vulgaris. Clin Dermatol 2005 May-Jun;23(3):223-6 [PubMed] [Crossref]
13. Kapoor S, Sikka P, Kaur GP. Pemphigus vulgaris of oral cavity: A case report with its treatment strategies. Int J Nutr Pharmacol Neurol Dis. 2013; 3(2):146-149. [Crossref]
14. Akman A, Kacaroglu H, Yilmaz E, Alpsoy E. Periodontal status in patients with pemphigus vulgaris. Oral Diseases 2008 Oct;14(7):640-3. [PubMed] [Crossref].
15. Arduino PG, Lopetuso E, Carcieri P, Giacometti S, Carbone M, Tanteri C, et al. Professional oral hygiene treatment and detailed oral hygiene instructions in patients affected by mucous membrane pemphigoid with specific gingival localization: a pilot study in 12 patients. Int J Dent Hyg. 2012 May;10(2):138-41 [PubMed] [Crossref].
16. Gambino A, Carbone M, Arduino PG, Carcieri P, Carbone L, Broccoletti R. Conservative approach in patients with pemphigus gingival vulgaris: a pilot study of five cases. Int J Dent. 2014; 2014:747506 [PubMed] [Crossref].
17. Tamgadge S, Tamgadge A, Bhatt DM, Bhalerao S, Pereira T. Pemphigus vulgaris. Contemp Clin Dent. 2011 2(2):134-7. [PubMed] [Crossref].
18. Prashanth J, Jesudoss Prabhakaran AC. The beneficial effect of Coenzyme Q in diabetic neuropathy: An overview. Int J Nutr Pharmacol Neurol Dis 2012; 2(2):80-83 [Crossref].

Received: 23 October 2018
Published online: 22 April 2019

back to Online Journal